Rigel Pharma

Five drugs, including two Novartis therapies, win EMA endorsement
Endpoints
Fri, 11/15/19 - 12:22 pm
EMA
Europe
Novartis
Mayzent
Isturisa
Roche
Polivy
Jazz Pharma
Sunosi
Rigel Pharma
Tavlesse
Aclaris hammered as hair loss drug flops in PhII, days after FDA took issue with Eskata ads
Endpoints
Thu, 06/27/19 - 09:37 am
Aclaris
Rigel Pharma
alopecia areata
ATI-502
clinical tirals